Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

B Clay Siegall

Affiliations

  • President And Ceo at Seattle Genetics Inc (SGEN), 2019-11-12
  • Director at Alder Biopharmaceuticals Inc (ALDR), 2019-10-24
  • Director at Ultragenyx Pharmaceutical Inc. (RARE), 2019-06-13
  • Director at Mirna Therapeutics Inc. (MIRN), 2016-09-06
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SGEN $108.08 20,799 Officer, Director 755,684 2019-11-08 Filing
SGEN $107.32 3,968 Officer, Director 755,684 2019-11-08 Filing
SGEN $105.93 2,120 Officer, Director 755,684 2019-11-08 Filing
SGEN $104.38 1,585 Officer, Director 755,684 2019-11-08 Filing
SGEN $82.01 14,420 Officer, Director 755,684 2019-10-08 Filing